Clinical Trial Update: Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens [Phase 4]

View source ↗

Summary

Phase 4 trial update of Peginterferon alfa-2a, ribavirin, and epoetin beta in coinfected HCV/HIV patients not responding to prior regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)
• epoetin beta (epoetin beta)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: Hepatitis C, HIV Infections | Phase 4 | Status: COMPLETED